Pages that link to "Q44486217"
Jump to navigation
Jump to search
The following pages link to Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients (Q44486217):
Displaying 50 items.
- Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese population (Q28083875) (← links)
- Influence of different allelic variants of the CYP3A and ABCB1 genes on the tacrolimus pharmacokinetic profile of Chinese renal transplant recipients (Q28244228) (← links)
- Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis. (Q33268368) (← links)
- Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans? (Q33632608) (← links)
- Clinical significance of ABCB1 genotyping in oncology (Q33951034) (← links)
- PharmGKB summary: cyclosporine and tacrolimus pathways (Q33989902) (← links)
- Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients (Q34065305) (← links)
- Retracted: Association of MDR1 Gene SNPs and Haplotypes with the Tacrolimus Dose Requirements in Han Chinese Liver Transplant Recipients (Q34081393) (← links)
- Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I. (Q34099716) (← links)
- Reduced methylprednisolone clearance causing prolonged pharmacodynamics in a healthy subject was not associated with CYP3A5*3 allele or a change in diet composition (Q34278794) (← links)
- Pharmacogenomics of MDR1/ABCB1 gene: the influence on risk and clinical outcome of haematological malignancies (Q34327594) (← links)
- Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis (Q34538009) (← links)
- MDR1 polymorphisms and idiopathic nephrotic syndrome in Slovak children: preliminary results. (Q34959857) (← links)
- Meta-Analysis of ABCB1 3435C>T Polymorphism and Colorectal Cancer (Q35071734) (← links)
- The interactions of age, genetics, and disease severity on tacrolimus dosing requirements after pediatric kidney and liver transplantation (Q35544537) (← links)
- From pharmacokinetics to pharmacogenomics: a new approach to tailor immunosuppressive therapy (Q35666588) (← links)
- Functional implications of genetic polymorphisms in the multidrug resistance gene MDR1 (ABCB1). (Q35814113) (← links)
- Investigation of CYP 3A5 and ABCB1 gene polymorphisms in the long-term following renal transplantation: Effects on tacrolimus exposure and kidney function (Q35943046) (← links)
- Modelling the influence of MDR1 polymorphism on digoxin pharmacokinetic parameters (Q35968259) (← links)
- Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects (Q35987461) (← links)
- Immunosuppressive drug monitoring - what to use in clinical practice today to improve renal graft outcome (Q36029868) (← links)
- Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2. (Q36120816) (← links)
- Clinical pharmacogenetics of immunosuppressive drugs in organ transplantation. (Q36120833) (← links)
- The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression? (Q36186945) (← links)
- New strategies in immunosuppression. (Q36267237) (← links)
- Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCG2: therapeutic implications (Q36301589) (← links)
- Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation? (Q36326210) (← links)
- Single nucleotide polymorphisms in human P-glycoprotein: its impact on drug delivery and disposition (Q36349672) (← links)
- Population pharmacokinetics and bioavailability of tacrolimus in kidney transplant patients (Q36379884) (← links)
- MDR1 gene polymorphisms and clinical relevance (Q36417994) (← links)
- Pharmacogenetic differences and drug-drug interactions in immunosuppressive therapy (Q36544981) (← links)
- Genetic predisposition and renal allograft failure: implication of non-HLA genetic variants (Q36554709) (← links)
- Clinical application of pharmacogenetics in gastrointestinal diseases (Q36613862) (← links)
- Novel Polymorphisms Associated With Tacrolimus Trough Concentrations: Results From a Multicenter Kidney Transplant Consortium (Q36630081) (← links)
- Effects of genetic polymorphisms on the pharmacokinetics of calcineurin inhibitors (Q36654010) (← links)
- New aspect of immunosuppressive treatment in liver transplantation. How could you induce tolerance in liver transplantation? (Q36738534) (← links)
- Race, Calcineurin Inhibitor Exposure, and Renal Function After Solid Organ Transplantation (Q36761340) (← links)
- ABCB1 polymorphisms may have a minor effect on ciclosporin blood concentrations in myasthenia gravis patients (Q36803373) (← links)
- Pharmacogenetics as a tool for optimising drug therapy in solid-organ transplantation (Q36916904) (← links)
- Kidney transplantation: current issues and future prospects (Q36938148) (← links)
- Pharmacogenetics may Influence Tacrolimus Daily Dose, but not Urinary Tubular Damage Markers in the Long-Term Period after Renal Transplantation. (Q37041351) (← links)
- Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update (Q37074093) (← links)
- Effect of the C3435T polymorphism of the multidrug resistance 1 gene on the severity of inflammatory bowel disease in Iranian Azeri Turks. (Q37100443) (← links)
- Pharmacogenetics of immunosuppressive drugs: prospect of individual therapy for transplant patients (Q37157896) (← links)
- Pharmacogenetics of Crohn's disease (Q37205946) (← links)
- ABCB1 genotypes predict cyclosporine-related adverse events and kidney allograft outcome (Q37211126) (← links)
- Pharmacogenetics in solid organ transplantation: current status and future directions (Q37218086) (← links)
- Genetic polymorphisms and the fate of the transplanted organ (Q37218129) (← links)
- Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant. (Q37397805) (← links)
- Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients (Q37439873) (← links)